In the late stages of muscle development, a unique cell population emerges that is a key player in postnatal muscle growth and muscle regeneration. The location of these cells next to the muscle fibers triggers their designation as satellite cells. During the healing of injured muscle tissue, satellite cells are capable of forming completely new muscle fibers or restoring damaged muscle fibers. A major problem in muscle healing is the formation of dysfunctional scar tissue, which leads to incomplete functional recovery. Therefore, the identification of factors that improve the process of muscle healing and reduce the formation of scar tissue is of great interest. Because satellite cells possess the capability of self-renewal, a unique feature of stem cells, they play a central role in the search for therapies to improve muscle healing. Growth factor-based and (satellite) cell-based therapies are being investigated to treat minor muscle injuries and intrinsic muscle defects. Major muscle injury that involves the loss of muscle tissue requires the use of scaffolds with or without (satellite) cells. Scaffolds are also being developed to generate muscle tissue in vitro. These approaches aim to restore the structure and function of the injured muscle without dysfunctional scarring.
INTRODUCTION S
KELETAL MUSCLE represents nearly half of the total body mass and thus is the most abundant tissue of the human body. The skeletal muscles induce smooth and coordinated body movements through their attachment to the skeleton. To ensure proper function, the skeletal muscles are highly vascularized and extensively innervated. A skeletal muscle is composed of many bundles of myofibers, which are the functional units. A single myofiber is derived from the fusion of numerous myoblasts and therefore contains many nuclei. Each myofiber contains many myofibrils, which are composed of repeating sarcomeres. A sarcomere is an arrangement of the contractile proteins myosin and actin, which form the thick and thin filaments, respectively (Fig. 1 ). These proteins are key elements for the contractile properties of skeletal muscle. For skeletal muscle to contract, the myofibers depolarize as a consequence of nerve activation. This results in the release of intracellular calcium from the sarcoplasmatic reticulum. Calcium causes binding of myosin to actin, and subsequently contraction of the myofibers and the entire skeletal muscle. Most human skeletal muscles contain a mixture of three different types of myofibers. Type 1 myofibers are slow twitch and fatigue resistant, type 2A myofibers are fast twitch and moder-ately fatigue resistant, and type 2B myofibers are fast twitch and not fatigue resistant. The proportions of these myofibers within skeletal muscles is dynamic and can change throughout life (1) (2) (3) (4) .
Skeletal muscles are able to self-regenerate after injury. Crucial cells in this process are the satellite cells, which are located between the sarcolemma and the basal lamina of the myofiber (5, 6) . After injury these cells are activated; they proliferate and eventually fuse to the damaged myofibers or fuse together to form new myofibers (1, (7) (8) (9) . Injury and diseases such as Duchenne muscular dystrophy (DMD) lead to impaired muscle function. The formation of a dysfunctional scar tissue during regeneration may account for this problem. Thus, the identification of factors that influence the regeneration process of injured muscle is of great interest. The aim of this review is to give an overview of muscle development and regeneration, as well as how this knowledge is now being used to develop treatment modalities for major muscle injuries or muscle disease.
EMBRYONIC MYOGENESIS

Somite development
In the early stages of embryonic development, the major function of gastrulation is to create a mesodermal layer between the ectoderm and the endoderm. The mesoderm forms the blood, blood vessels, bones, cartilage, connective tissue, and the muscles of the body trunk. On either side of the neural tube, this mesoderm is divided into the axial mesoderm (notochord), intermediate mesoderm, paraxial mesoderm, and the lateral plate mesoderm (10) . With the exception of the craniofacial muscles, nearly all embryonic skeletal muscles are derived from the paraxial mesoderm. First the paraxial mesoderm separates into cell clusters, called the somites, starting at the head region and sequentially added caudally. Cells of the ventral part of the somites undergo an epithelial-to-mesenchymal transition, thereby forming the sclerotome, which eventually forms the vertebrae and ribs. In the chick, this process is characterized by the down-regulation of Pax3 and Pax7, two members of the family of paired/homeodomain transcription factors (Fig. 2) . Members of this family play an essential role in embryonic organogenesis (11) . Cells of the dorsal part of the somites maintain Pax3 and Pax7 expression, and form the dermomyotome. This dermomyotome is responsible for the musculature and the dermis and is divided into an epaxial and hypaxial part, which forms the deep back muscles and the intercostal, abdominal, and limb muscles (10) .
Myotome development
A crucial step in the formation of skeletal muscle is the appearance of the myotome (Fig. 2) . First, muscle progenitors cells delaminate from the four edges of the dermomyotome (12) . In addition, muscle progenitor cells migrate into the limb buds. It has been described that cMet, a tyrosine kinase receptor that binds hepatocyte growth factor (HGF) (13), and Pax3 are major contributors to this delamination and migration, because mouse embryos lacking functional c-Met and Pax3 do not form skeletal muscle in the limbs. At the edges of the dermomyotome, Pax3 is also important to the survival of these cells (14) (15) (16) (17) . These delaminating progenitor cells down-regulate Pax3 and become myoblasts through the action of the myogenic regulatory factors (MRFs), a family of basic helix-loop-helix transcription factors that regulate myogenesis. These myoblasts increase their expression of Myf5, Mrf4, and MyoD (18) (19) (20) , and differentiate into myocytes through the action of myogenin, Mrf4, and MyoD (21) . The myocytes eventually fuse and mature into multinucleated muscle fibers forming a continuous muscle layer, the myotome. It is known that these GREFTE ET AL.
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FIG. 1.
The structure of skeletal muscle. Skeletal muscle is made up of clusters of myofibers. A single myofiber is composed of many myofibrils, which contain repeating sarcomeres. Each sarcomere contains the proteins actin and myosin, which represent the thin and thick filaments, respectively. These proteins are responsible for muscle contraction.
processes are influenced by signals from adjacent structures. Sonic hedgehog (Shh) and Wnt proteins, both representing a family of secreted signaling molecules, are involved in muscle development. These proteins are released from the neural tube, notochord, and surface ectoderm, and provide stimulatory signals during myogenesis. Bone morphogenic proteins (BMPs), another family of secreted signaling proteins involved in developmental processes, are released from the neural tube and the lateral plate mesoderm and inhibit myogenesis (1, (22) (23) (24) (25) .
Embryonic muscle and satellite cells
Given that the dermomyotome progressively disintegrates (10) and the myotome is already post-mitotic, these structures cannot account for the massive muscle development in the embryo. Several groups describe that cells expressing Pax3 and Pax7, but not the myogenic markers, migrate from the central dermomyotome directly into the myotome. During muscle development, these cells contribute to muscle growth and are maintained within the muscle mass. Before skeletal muscle forms in the limb buds, these precursor cells probably proliferate extensively to create the skeletal muscle tissue (26) (27) (28) (29) . As mentioned before c-Met and Pax3 are involved in the migration of cells from the somite into the limb buds, and only upon arrival in the limb do these cells start to express MyoD and Myf5 (30) . Furthermore, the Pax3-and Pax7-positive cells derived from the central dermomyotome also give rise to most if not all satellite cells, which emerge during the later phases of embryonic development (26) (27) (28) . Although the paraxial mesoderm in the embryonic body is completely segmented into somites, in the head it is incompletely segmented into seven mesenchymal structures, called somitomeres. Most head muscles such as the matistactory, jaw opening, and eye muscles, are derived from the paraxial head mesoderm, but the tongue muscles are derived from the somites (10, 31) . In addition, differences have been described in the regulation of myogenesis in the head and these are reviewed elsewhere (1, 31, 32) During embryonic development, two distinct types of skeletal muscle fibers appear. The first muscle fibers that emerge are called primary or embryonic fibers; the secondary or fetal fibers arise later. The primary and secondary fibers have distinct morphological and biochemical properties and can be classified into slow-twitch and fast-twitch fibers (33) (34) (35) (36) . Moreover, it seems that this
The formation of the somites and the myotomes. The paraxial mesoderm, which gives rise to most of the skeletal muscle, segments into the somites. Eventually the somites differentiate into a sclerotome and a dermomyotome. In the chick, Pax3 and Pax7 expression is down-regulated in the sclerotome, but in the dermomyotome both are maintained. After the formation of the sclerotome and the dermomyotome, muscle progenitor cells delaminate from the four edges of the dermomyotome. These cells down-regulate their Pax3 expression and up-regulate the expression of myogenic regulatory factors, such as Mrf5, Myf4, MyoD, and myogenin. This results in the differentiation and fusion of the muscle progenitor cells, which leads to the formation of the myotome. In time, the dermomyotome disintegrates and muscle progenitor cells, expressing Pax3 and Pax7, migrate into the myotome. These cells contribute to the massive muscle development in the embryo and give rise to most of the satellite cells. commitment is independent from the surroundings and occurs in the somite (37) . Toward the end of embryogenesis, the satellite cells appear. They are the major players in postnatal muscle growth and regeneration.
MUSCLE REGENERATION
In general, adult skin wound healing occurs in three overlapping phases: inflammation, tissue formation and tissue remodeling (38) . Wound healing proceeds similarly in other tissues such as muscle (2) . A drawback of wound healing often is the formation of scar tissue (fibrosis), which can give esthetic as well as functional problems.
Fetal tissue regeneration
In contrast with adult skin wound healing, fetal wound healing of the skin can occur without the formation of scar tissue. Since this observation, the search for factors that contribute to scarless healing was of great interest because these factors have a promising role in preventing scar formation in adult wound healing (39) (40) (41) . In the fetus, rapid wound closure is induced without scab formation and inflammation and with specific cytokine levels. Additionally, matrix deposition is rapid and similar to the uninjured fetal skin, whereas the extracellular matrix is rich in hyaluronic acid. Several studies indicate that the fetal environment is not essential for scarless tissue repair and that intrinsic factors of the tissue itself are vital (42, 43) . However, not all fetal wounds heal without scar tissue, and healing takes place only in fetuses up to a certain gestational age (44) (45) (46) . Also wound size is important, as the extent of scarring increases with increasing wound size (47, 48) . In contrast to the healing of fetal skin, wounds in gastric tissue, intestine, and nerve tissue always heal with scar formation (49) (50) (51) . Moreover in diaphragmatic wounds, muscle regeneration is absent, and scar tissue forms (52) . With the exception of this study, there is little further information on fetal muscle healing.
Adult tissue regeneration
Similar to the healing of adult skin, the healing of adult muscle injury caused by trauma occurs in three overlapping phases. As described, these phases include inflammation, tissue formation, and tissue remodeling resulting in the formation of scar tissue (fibrosis). After muscle injury, disruption of the myofiber plasma membrane initiates an influx of extracellular calcium, leading to calcium-dependent proteolysis (53) (54) (55) . This results in necrosis and degeneration of damaged myofibers, which is restricted to the damaged site through the formation of a contraction band that seals off the defect (56) . At the site of injury, blood vessels are also damaged, allowing the invasion of inflammatory cells. Factors are released in the injured muscle tissue that attract and activate inflammatory cells, which secrete chemotactic factors to attract more inflammatory cells. Neutrophils are the first inflammatory cells at the site of injury, and later macrophages arrive to phagocytose muscle debris (1) . Interestingly, satellite cells and macrophages interact to amplify chemotaxis and thereby enhance inflammation. Macrophages may also support satellite cell survival by cell-cell contact and the release of soluble factors (57) . Additionally, macrophage infiltration leads to increased satellite cell proliferation and differentiation. After macrophage depletion, muscle regeneration is completely absent (58).
In conclusion, macrophages are not only important for the resolution of necrosis but are also involved in the induction of muscle regeneration (59) .
Satellite cells
At the site of injury, many growth factors are expressed and several of these are able to activate satellite cells. Examples are members of the fibroblast growth factor (FGF) and transforming growth factor-␤ (TGF-␤) families, insulin-like growth factor-I and -II (IGF-I, IGF-II), hepatocyte growth factor (HGF), and interleukin-6 (IL-6). The functions of these factors are reviewed extensively elsewhere (1,2,22,60). Normally, satellite cells are quiescent, located between the basal lamina and the sarcolemma of myofibers, and express Pax7 (61, 62) . Pax7 in combination with M-cadherin (Fig. 3) , a calcium-dependent cell adhesion molecule, c-Met, or other markers should be used to identify satellite cells (22) . However, up to now, there is no unique marker for quiescent or activated satellite cells. Upon injury, activated satellite cells either migrate to adjacent myofibers if the basal lamina is de-GREFTE ET AL.
FIG. 3.
Identification of a satellite cell in rat muscle by immunostaining with Pax 7 (red), M-cadherin (green) and DAPI (blue). (S. Grefte, unpublished results). This figure will appear in color online. stroyed or migrate under the basal lamina to the site of injury (22) . The activation of satellite cells is similar to embryonic myogenesis, which is controlled by Pax3, Pax7 and Myf5 (63) (Fig. 4) . First the activated satellite cells up-regulate either MyoD or Myf5, but eventually these factors are co-expressed. During this stage, the satellite cells become proliferative, and are also known as myoblasts. Down-regulation of Pax3 (63) and Pax7 (61, 64) , and up-regulation of myogenin and Mrf4 lead to terminal differentiation of these myoblasts. Pax3 and Pax7 activate myogenin via up-regulation of MyoD, but Myf5 is able to activate myogenin directly. Ultimately, these differentiated myoblasts either fuse to each other, creating new myofibers, or fuse to existing damaged myofibers for repair (1, (7) (8) (9) . These myofibers are still small, and the nuclei are located near the center of the myofiber. Maturation of these myofibers is characterized by an increase in size, and the movement of the nuclei to the periphery (22) . Next to growth factors, Notch, Shh, and Wnt, which are important in muscle embryogenesis, may also be involved in satellite cell activation and postnatal muscle regeneration (60) .
Another essential factor in the function of satellite cells is the muscle environment. In aging muscle, regeneration is less efficient and the number of satellite cells declines. Because exposure of aged mice to serum of young mice restores muscle regeneration effectively (65), the aged stem cells must still have retained their regenerative capacity (65) (66) (67) . These local factors are unknown, and further research is needed to identify them. Besides satellite cells, other cell types seem to be involved in muscle regeneration. Some studies suggest a minor role for nonmuscle stem cells and for muscle-derived progenitor cells other than satellite cells (1, 68) . However, the exact functions of satellite cells and other cell types in regenerating muscle defects remain unclear. Moreover, evidence exists that satellite cells constitute a heterogeneous population (69) . Also, satellite cell markers such as M-cadherin and Myf5 seem to be heterogeneously expressed (70) , but Pax7 is expressed in almost all quiescent satellite cells (61, 62) .
Self-renewal of satellite cells
A crucial characteristic of satellite cells is the capacity of self-renewal, which is a unique feature of all stem cells. Without self-renewal the number of satellite cells would decline after repetitive muscle injury and also during normal tissue turnover. Direct evidence for the selfrenewal of satellite cells was provided using genetically labeled myofibers, but the exact mechanism has not yet been determined (71) . Two mechanisms have been proposed that result in satellite cell maintenance (68, 72) . Asymmetric division results in the formation of two daughter cells, of which one remains quiescent while the other undergoes myogenic activation and differentiation. Alternatively, symmetric division results in the activation and proliferation of all daughter cells. While the bulk of these proliferated cells down-regulate Pax7 and differentiate into new myofibers, a few cells retain Pax7 expression, return to their quiescent state, and repopulate the satellite cell pool (61, 64) . In Pax7 knockout mice, satellite cells are still present directly after birth, but their number declines during postnatal development. It was also shown recently that in Pax7 knockout mice apoptosis of satellite cells occurs (63) . In contrast, Pax3 is essential for the survival of cells in the hypaxial dermomyotome as described before.
Fibrosis
At the site of injury, fibrosis may also occur leading to the formation of scar tissue (73) . Similar to skin wound healing, a provisional matrix provides an initial extracellular matrix for cell invasion. In time, (myo)fibroblasts begin to produce extracellular matrix components like fibronectin, followed by type III collagen, and ending with excessive production of type I collagen. Finally, after tissue remodeling and apoptosis of the myofibroblasts, a nearly acellular scar tissue is formed (3). It is unknown whether regenerated myofibers will eventually fuse and fully regenerate the muscle tissue, but most muscle injuries heal without dysfunctional scar tissue. In contrast, excessive fibroblast proliferation may occur in large muscle injuries, resulting in a scar that limits full muscle regeneration (74, 75) . Using a clonal population of musclederived stem cells it was shown that myogenic precursor cells are able to differentiate into myofibroblasts after muscle injury (76) . TGF-␤1 is involved in scarring during wound healing in the skin (38) . In muscle, TGF-␤1 is highly expressed at the site of injury, and it is able to induce myofibroblast differentiation of muscle-derived stem cells in vitro (76) . This suggests that some of the (myo)fibroblasts responsible for scar formation might be derived from myogenic cells such as satellite cells.
In summary, the function of satellite cells during muscle regeneration is regulated by many growth factors and cytokines. Their capacity of self-renewal provides a source of satellite cells for muscle regeneration throughout life. Although most muscle injuries heal without dysfunctional scar tissue, this may occur in large muscle defects.
IMPROVING MUSCLE REGENERATION
Growth factor-based therapy
The effects of growth factors on the activation, proliferation, and differentiation of satellite cells have been re-IMPROVING MUSCLE REGENERATION AFTER INJURY viewed elsewhere (1,2,22,60). Growth factors with stimulatory effects might be used in vivo to enhance the regeneration of muscle tissue. Indeed, it appears that the administration of growth factors after muscle injury may improve the healing process. In mouse models for muscle strain (77), contusion (78) , and laceration (79, 80) injuries, direct injection of IGF-I and FGF-2, and to a lesser extent nerve growth factor (NGF), improved healing of the muscle. This was indicated by an increase in the number and the diameter of regenerated myofibers. Additionally, the strength of the myofibers improved. The administration of decorin, an inhibitor of TGF-␤, also induced muscle healing, and in combination with IGF-I it seems to be the best strategy to improve muscle healing (80) . However, based solely upon the strength of the myofibers, the administration of decorin alone showed the best improvement. These conflicting results stress the use of histological as well as functional parameters to evaluate muscle regeneration. Because TGF-␤ is considered to be involved in fibrosis, the inhibition of this growth factor might reduce scar formation during muscle regeneration. In fact, the administration of decorin indeed inhibits fibrosis (80) . In contrast, it was also shown that administration of FGF-2 did not improve muscle regeneration (81) . Therefore, it is important to exactly identify which growth factors enhance muscle regeneration in vivo and also at which concentration, location, and time point they should be administered. Thus, growth factors seem to improve muscle healing after minor injury. However, for intrinsic muscle defects such as DMD or large muscle defects, growth factorbased therapy might not be the appropriate strategy. To treat DMD, the use of cell-based therapy is a better solution. For major muscle injuries, scaffold-based therapy to fill up the large defect is the best method. These scaffolds can also be loaded with growth factors and/or myogenic cells.
Cell-based therapy
To regenerate muscle through the delivery of exogenous cells such as myofibers or satellite cells, it is crucial that these cells not only regenerate the damaged muscle but also replenish the satellite cell pool. This allows a long-term normal tissue maintenance and regenerative capacity. Although there is evidence that the dystrophic muscle environment is hostile for muscle regeneration (82) , the mdx mouse model has been used extensively to study muscle regeneration after cell transplantation. The mdx mouse lacks dystrophin, a structural protein that is mutated in DMD patients. Repetitive injections of notexin after the transplantation of clones of myoblasts into irradiated mdx nu/nu mouse muscle resulted in new myofibers of donor origin (83) . The formation of new muscle after repetitive muscle damage indicates that a new satellite cell population was established (83) . Labeling studies showed that myoblasts repaired the injured muscle fibers after transplantation and formed new satellite cells (84, 85) . Furthermore, labeled satellite cells were detected in host muscle fibers, and isolated satellite cells from these fibers were also able to become active and to proliferate (86) . Grafting of myofibers that contain satellite cells resulted in the regeneration of damaged muscle and the expansion of the satellite cell pool (71). Moreover, grafting the satellite cells, which were isolated from these myofibers, generated clusters of new myofibers. This indicates that the isolation of satellite cells from the myofiber does not impair the myogenic potential of these cells (71) . Additionally, a pure population of myogenic cells expressing Pax3, Pax7, and CD34 contributed to muscle regeneration and the formation of new satellite cells (87) . However, cultured satellite cells gradually loose their myogenic potential, and the transplantation of these cells leads to less efficient muscle regeneration (87, 88) . Freshly isolated satellite cells may induce muscle regeneration more efficiently, but the small number of isolated satellite cells might be a problem. Therefore methods for culturing satellite cells must be developed in which they maintain their myogenic properties.
Unfortunately, it has also been shown that the majority of the myoblasts die after transplantation in mdx mice (89) (90) (91) . Inflammation may be involved because infection of the myoblasts with a retroviral vector containing the IL-1 receptor antagonist partly prevented the observed cell death (90) . Although most of the transplanted cells died, a minority of myogenic cells were able to survive and to regenerate the host muscle (91) . Additionally, a specific myogenic cell population was enriched based upon their adhesion capabilities. These cells were able to survive after transplantation and fused with host myofibers, thus demonstrating their regenerative capacity (90) . Two additional myogenic populations were found based upon M-cadherin and CD34 expression (92) . In this study, these two markers could not be co-localized in skeletal muscle of normal mice, but cells expressing M-cadherin or CD34 both reside between the basal lamina and the sarcolemma of the myofibers, which is also the niche of satellite cells. However, in another study, M-cadherin-positive satellite cells were also positive for CD34 (70) . Cloned myogenic cells from the CD34 ϩ population enhanced muscle regeneration, and partially restored dystrophin expression (92) . In another study, three myogenic cell populations were found based upon their adherence capacity. Two of these cell populations represented the satellite cells and showed limited capacity to regenerate the host muscle. However, the third cell population showed a strong capacity to improve muscle regeneration. These cells were long-time proliferative and also called muscle derived cells (MDSCs) (93) . Interestingly, these cells did not activate T cells, indicating that they were not rejected by the immune system of the host. However, it was also shown that, on the basis of the mass and functional properties of the muscle, transplantation of primary myoblasts or the same MDSCs as described before (93) did not induce muscle regeneration in mdx mice (94) .
These results suggest that myoblast transplantation is helpful for the treatment of DMD by the fusion of myoblasts with host muscle fibers and restoring dystrophin expression, but in human experiments this strategy was unsuccessful. The translation from mice to humans might have been made too easily. Human muscles might be too large to allow transplanted myoblasts to migrate throughout the entire muscle. A discussion of these problems and the treatment of DMD in humans has been published elsewhere (95) . In a recent study in the golden retriever muscular dystrophy (GRMD) model, a new therapy modality was developed for the treatment of DMD. The transplantation of autologous mesangioblasts transfected with small dystrophin genes resulted in the expression of dystrophin in host muscle and the formation of functional muscle with a normal morphology (96) .
In conclusion, most of these studies show the potential of transplanting myoblasts and MDSCs into muscle tissue to produce new muscle fibers or to restore dystrophin expression in host muscle fibers for the treatment of DMD. Moreover, the transplanted myoblasts are also able to create a new satellite cell pool, necessary for mus-IMPROVING MUSCLE REGENERATION AFTER INJURY cle regeneration throughout life and normal tissue turnover. Therefore the combination of transplanted cells with suitable scaffolds might offer new strategies for the repair of major muscle damage.
Scaffold-based therapy
In contrast to the transplantation of myoblasts and the use of growth factors to heal minor muscle injuries, these methods might not be appropriate for large defects. The application of a three-dimensional scaffold, which fills up the defect and induces the formation of new muscle, seems more suitable. The scaffold can be seeded with myoblasts or other myogenic cells, and can be implanted into a large muscle defect to improve muscle regeneration. However, the transplantation of a collagen disc seeded with or without myoblasts into an abdominal wall muscle defect in rats did not induce muscle formation (97) . Similar results were obtained after the transplantation of an acellular muscle matrix to reconstruct an abdominal wall muscle defect in rabbits (98) and rats (99) and a dorsal muscle defect in rats (100) . Eventually these constructs were replaced by fibrous tissue (98-100). However, seeding the matrix with autologous satellite cells reduced the inflammation, and fibrosis occurred at the edge of the implant. This indicates that satellite cell seeding improves the biocompatibility of the scaffold. In vitro studies showed that an acellular muscle matrix supports the growth and differentiation of satellite cells isolated from rats, but in vivo studies showed no convincing evidence of skeletal muscle formation inside the matrix after transplantation into a dorsal muscle defect in rats (100). However, electric activity was detected, indicating that skeletal muscle fibers were present within the matrix (99) . This result shows the potential of using constructs seeded with myoblasts to reconstruct injured muscle. Additionally, transplantation of a muscle matrix seeded with male rat myoblasts into full-thickness abdominal wall defects of female rats resulted in the formation of a dense capillary network, skeletal muscle fibers, and evidence for nerve formation (101) . This matrix stained positively for FGF-2 and TGF-␤, which could play a role in the regeneration of injured muscle. It has also been shown that muscle formation occurred only at the border of the matrix after the transplantation of an autologous myoblast-seeded muscle matrix construct into the abdominal muscle of rats (102) .
Thus, it seems that growth factors inside the matrix have a positive effect on seeded myoblasts and improve the formation of muscle fibers. The addition of HGF and FGF-2 to alginate scaffolds seeded with myoblasts greatly increased the viability of these cells (103) . Transplantation of such a scaffold seeded with myoblasts resulted in enhanced muscle regeneration by the engrafted donor cells (104) . Also other biomaterials were used as a three-dimensional matrix to reconstruct muscle tissue. The implantation of degradable polyglycolic acid (PGA) meshes (105, 106) , alginate, and hyaluronic acid constructs (107) , all seeded with myoblasts, into a nonmuscle environment resulted in vascularization and muscle formation. Using fibrin as a three-dimensional matrix, in vitro studies showed that myoblasts can fuse into myotubes with physiological functions, such as force production (108) . After injecting fibrinogen with male myoblasts into a muscle defect of female rats, the fibrin matrix was eventually dissolved and the myoblasts fused with the host muscle (109) . More importantly, no inflammation was observed and fibrosis was absent (109) . However, full integration of the scaffolds seeded with myoblasts into the host muscle and total functional recovery without scarring still remain to be realized.
In summary, three-dimensional scaffolds might have advantages in the treatment of large muscle defects. Seeding of the scaffold with myoblasts appears to be essential to induce the formation of new muscle mass. Furthermore, the addition of growth factors might improve the proliferation, migration and fusion of these myoblasts into new myofibers. A crucial aspect is the vascularization and innervation of the construct. It is important to keep in mind that, in line with the problems of the treatment of DMD in humans, these studies were carried out in the muscles of small animals. Thus, caution must be taken in the translation of the data to humans with larger muscles. The migration of myoblasts out of the scaffold, and the diffusion of signaling molecules and nutrients might be different.
CONCLUSION
Several strategies are being investigated to improve muscle regeneration after muscle trauma. For small defects, the administration of appropriate growth factors might increase satellite cell activation and improve muscle regeneration, while inhibiting fibrosis. The application of satellite cells or other myogenic cells capable of forming new muscle tissue might also improve muscle regeneration. These cells, as well as genetically corrected satellite cells, might also be used to restore intrinsic molecular defects such as DMD. However, for large muscle defects, suitable scaffolds must be used to induce muscle regeneration. These scaffolds should act as a temporary guide for host muscle cells or seeded satellite cells. Additionally, growth factors can be introduced into the scaffolds to create a suitable microenvironment for satellite cells. It is essential that these scaffolds: (1) initially provide mechanical stability to the defect, (2) induce satellite cell proliferation and differentiation into mature muscle, (3) induce fusion and alignment of myofibers with host myofibers, and (4) provide a niche to harbor GREFTE ET AL. satellite cells needed for normal tissue turnover and for future muscle regeneration. Furthermore, for a complete and functional recovery of damaged muscle the new tissue must be well vascularized and innervated. The ultimate goal of these strategies is to induce rapid muscle regeneration, leading to a functional muscle without the formation of dysfunctional scar tissue.
